Thrilled to attend #AACR25 in #Chicago! Can’t wait to learn from brilliant minds and connect with inspiring people from around the world. Let the adventure begin!
Today, we pause to honor the victims of the Holocaust and reflect on the immense suffering endured by millions, with special remembrance of Polish victims who are often overlooked in the broader narrative.
Auschwitz-Birkenau, located in German occupied Poland it became the center of this atrocity because of convenience and Poland since was the haven for Europe’s largest Jewish population.
Initially designed for Polish prisoners prisoners, it later symbolized the German regime’s systematic extermination of Jewish people.
Yet, Poles suffered uniquely under the occupation, targeted as Germany’s first victims.
For nearly three years, Poles were killed at a ratio of 10 to 1 compared to Jews, subjected to forced labor, mass executions, and efforts to erase their culture.
In Auschwitz alone, tens of thousands of Poles, intellectuals, patriots, priests, and ordinary civilians were murdered.
This grim history underscores the resilience of the Polish people.
The Polish underground, civilians, and government-in-exile risked everything to resist German oppression and aid their Jewish neighbors, something that is also often overlooked or even revised.
On this solemn day, let us honor their sacrifice and bravery.
Let us keep alive the truth and memory of those who perished.
Photo: Czeslawa Kwoka, a young Polish girl that was murdered by the Germans
The Lab #TourDeForce June champs:
- Polina Kaidun 🟡🎽 for novel #Tcell constructs
- Britta Statz 🟢🎽for screening of #bispecific costimulators
- Martina Lutz ⚪️🔴🎽 for target restricted checkpoint inhibitors
- Nisha Prakash Eddie the 🦅🎽 for perseverance despite no new data
We are starting a phase-I #clinicaltrial for our #peptide#vaccine against acute myeloid leukemia (AML). We are
looking for #AML#patients after first-line therapy and aim to avoid relapse due to minimal residual disease.
For more information, check out:
https://t.co/8ej98vFrB6
NK-cell therapies are safer than T-cell therapies and offer other advantages but require upgrades to overcome their limited lifespan and susceptibility to immunosuppression @Nature @ImmYounology
https://t.co/ofbnn1IDv9
Happy and proud to be part of the ENDO-RELIEF project in collaboration with @MMaerklin from @Salihlab supported by the @BMBF_Bund aiming to better understand the development of #endometriosis.
https://t.co/84DC5V7Gla
🏆 May Lab #TourDeForce Heroes! 🎉
🟡🎽Tatjana Schreiber leads with precision in mentoring
🟢🎽Emma Nill excels in #bispecific constructs cloning
⚪️🔴🎽Nisha Prakash masters experimental optimization of #Tcells
Polina Kaidun bravely tackles hurdles with the Eddie the 🦅🎽 spirit!
💫 Exciting news! Our B7H3xCD3 #bispecific#antibody CC-3 shows promise in fighting bone & soft tissue sarcomas. Congrats to Samuel Holzmayer & team! @MMaerklin@CoE_iFIT#immunotherapy
➡️https://t.co/MGPT9YDAF2
Happy to see the latest study of Samuel Holzmayer and @KauerJoe et al on the effect of Asciminib on Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts published in @Cancers_MDPI 👏🏻
@MMaerklin
https://t.co/TXn4EI5Eoj
👩🔬We are part of @Der_GirlsDay on April 25, 2024! You want to learn more about the exciting world of #CancerResearch? Then register for one of our four #workshops! 🥼🔬Put on your lab coat and head for the microscopes! #womeninscience#girlsday ➡️https://t.co/E8Z7vVFuGu